Loading...

Luke Anthony Wittenburg

TitleASST PROF-SFT-VM
InstitutionUniversity of California Davis
DepartmentVM: SURG/RAD SCIENCE
Address218 CCAH
CA 95616
Phone530-754-5711
Emaillwittenburg@ucdavis.edu
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Withers SS, York D, Johnson E, Al-Nadaf S, Skorupski KA, Rodriguez CO, Burton JH, Guerrero T, Sein K, Wittenburg L, Rebhun RB. In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Vet Comp Oncol. 2018 Aug 08. PMID: 30088848.
      View in: PubMed
    2. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg L. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018 Jul; 82(3):178-183. PMID: 30026641.
      View in: PubMed
    3. Herndon AK, Quimby JM, Sieberg LG, Davis L, Caress AL, Ligas S, Hansen RJ, Wittenburg L, Gustafson DL. Preliminary pharmacokinetics of intravenous and subcutaneous dolasetron and pharmacodynamics of subcutaneous dolasetron in healthy cats. J Feline Med Surg. 2017 Sep 01; 1098612X17729310. PMID: 28905667.
      View in: PubMed
    4. Zajic LB, Herndon AK, Sieberg LG, Caress AL, Morgan PK, Hansen RJ, Wittenburg L, Gustafson DL, Quimby JM. Assessment of absorption of transdermal ondansetron in normal research cats. J Feline Med Surg. 2017 Dec; 19(12):1245-1248. PMID: 28112563.
      View in: PubMed
    5. Worley DR, Hansen RJ, Wittenburg L, Chubb LS, Gustafson DL. Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats. Anticancer Res. 2016 10; 36(10):5071-5078. PMID: 27798866.
      View in: PubMed
    6. Benson KK, Zajic LB, Morgan PK, Brown SR, Hansen RJ, Lunghofer PJ, Wittenburg L, Gustafson DL, Quimby JM. Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study. J Feline Med Surg. 2017 Oct; 19(10):998-1006. PMID: 27613493.
      View in: PubMed
    7. Colbath AC, Wittenburg L, Gold JR, McIlwraith CW, Moorman VJ. The Effects of Mepivacaine Hydrochloride on Antimicrobial Activity and Mechanical Nociceptive Threshold During Amikacin Sulfate Regional Limb Perfusion in the Horse. Vet Surg. 2016 Aug; 45(6):798-803. PMID: 27416788.
      View in: PubMed
    8. Watson MK, Wittenburg L, Bui CT, Jarosz KA, Gustafson DL, Johnston MS. Pharmacokinetics and bioavailability of orbifloxacin oral suspension in New Zealand White rabbits (Oryctolagus cuniculus). Am J Vet Res. 2015 Nov; 76(11):946-51. PMID: 26512539.
      View in: PubMed
    9. Myers JA, Wittenburg L, Olver CS, Martinez CM, Bright JM. Pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban after oral and intravenous administration to cats. Am J Vet Res. 2015 Aug; 76(8):732-8. PMID: 26207972.
      View in: PubMed
    10. Barnard RA, Wittenburg L, Amaravadi RK, Gustafson DL, Thorburn A, Thamm DH. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy. 2014 Aug; 10(8):1415-25. PMID: 24991836; PMCID: PMC4203518.
    11. Arnold TS, Wittenburg L, Powell CC. Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs. Vet Ophthalmol. 2014 Sep; 17(5):328-33. PMID: 23802568.
      View in: PubMed
    12. Wittenburg L, Ptitsyn AA, Thamm DH. A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma. J Cell Biochem. 2012 Mar; 113(3):773-83. PMID: 21976144; PMCID: PMC4667946.
    13. Wittenburg L, Gustafson DL. Optimizing preclinical study design in oncology research. Chem Biol Interact. 2011 Apr 25; 190(2-3):73-8. PMID: 21296059.
      View in: PubMed
    14. Wittenburg L, Gustafson DL, Thamm DH. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Clin Cancer Res. 2010 Oct 01; 16(19):4832-42. PMID: 20705615; PMCID: PMC2948605.
    15. Wittenburg L, Bisson L, Rose BJ, Korch C, Thamm DH. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin. Cancer Chemother Pharmacol. 2011 Jan; 67(1):83-92. PMID: 20306194; PMCID: PMC2916050.